Researchers at Boston Children's Hospital and the Massachusetts Institute of Technology are testing ways to delay the rise of neuropathic pain through an anesthetic derived from shellfish toxin, according to News-Medical.
The anesthetic method has the potential to allow physicians to keep injuries from evolving into neuropathic pain, a chronic form of pain that arises from flawed signals transmitted to damaged nerves.
The team combined saxitoxin, a powerful local anesthetic, with dexamethasone to prolong saxitoxin's effects. The two ingredients contain liposomes for nontoxic delivery to the site of nerve or tissue damage.
More Articles on Anesthesia:
Somnia Anesthesia to Offer Webinar on Anesthesia Career Trends
Physician Lawmakers Concerned by Policy to Allow Patients to Report Medical Mistakes
Personally Performed Anesthesia Payments to be Reviewed by Office of Inspector General
The anesthetic method has the potential to allow physicians to keep injuries from evolving into neuropathic pain, a chronic form of pain that arises from flawed signals transmitted to damaged nerves.
The team combined saxitoxin, a powerful local anesthetic, with dexamethasone to prolong saxitoxin's effects. The two ingredients contain liposomes for nontoxic delivery to the site of nerve or tissue damage.
More Articles on Anesthesia:
Somnia Anesthesia to Offer Webinar on Anesthesia Career Trends
Physician Lawmakers Concerned by Policy to Allow Patients to Report Medical Mistakes
Personally Performed Anesthesia Payments to be Reviewed by Office of Inspector General